Novel Treatment Strategies for Targeting Posttraumatic Epilepsy
针对创伤后癫痫的新治疗策略
基本信息
- 批准号:8597337
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-10-01 至 2014-09-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAfghanistanApplications GrantsAttenuatedBehavioralBrain InjuriesChronicClinicClinicalClinical TrialsCognitiveCombined Modality TherapyConvulsantsCraniocerebral TraumaDataDevelopmentDiseaseDoseDown-RegulationDropsElectrophysiology (science)EpilepsyFDA approvedFunctional disorderGABA ReceptorGlutamatesGrantHippocampus (Brain)HourHumanImpact SeizuresImpaired cognitionIn Situ HybridizationIn VitroIncidenceInjuryInvestigationIraqLaboratoriesLeadLiquid substanceMessenger RNAMilitary PersonnelModelingModificationMorbidity - disease rateN-Methyl-D-Aspartate ReceptorsNR2B NMDA receptorNeuronsNeurotransmitter ReceptorOutcomeOutcome MeasurePatternPentylenetetrazolePercussionPharmaceutical PreparationsPharmacotherapyPopulationPredispositionPreventionProteinsRattusResearchResearch PersonnelRisk FactorsSeizuresSeriesSeveritiesSoldierStatus EpilepticusSyndromeTestingTherapeuticTimeToxic effectTraumaTraumatic Brain InjuryTreatment EfficacyUnited StatesVeteransWarWestern Blottingaxonal sproutingbasecentral nervous system injuryclinical efficacyclinically relevantcognitive functioneffective therapyefficacy testingexperienceimprovedmortalitymossy fibernatural hypothermianeuron lossneuronal excitabilityneuronal patterningnovelpatient populationpre-clinicalpreclinical studypreventpublic health relevancereceptorreceptor functionreceptor upregulationresearch studyresponsetreatment strategy
项目摘要
DESCRIPTION (provided by applicant):
Posttraumatic epilepsy (PTE) is a frequent consequence of traumatic brain injury (TBI) in both the civilian and military population. Although some investigations have been conducted to evaluate the pathophysiology of this clinical syndrome, no proven therapies have been validated in the human PTE population. Our recent findings demonstrate that moderate fluid percussion brain injury in rats leads to reduced seizure threshold weeks to months after trauma. This alteration in neuronal and circuit excitation is supported by behavioral, electrophysiological and histopathological data. In addition, preliminary findings summarized in this grant proposal demonstrate that modest posttraumatic hypothermia (33oC) induced 30 minutes after TBI increases seizure threshold, reduces neuronal vulnerability and aberrant axonal sprouting in the hippocampus. Therefore, the present proposal will build on these exciting findings by investigating receptor-dependent mechanisms of action on the development of seizure susceptibility after TBI and will for the first time utilize a combination therapeutic approach including modest hypothermia and neurotransmitter receptor directed therapy to improve traumatic outcome and reduce the incidence of PTE. In Specific Aim 1, the impact of injury severity on subacute (1 and 4 weeks) and chronic (12 wks and 1 yr) seizure susceptibility using clinically relevant outcome measures including electrophysiology and cognitive assessment will be determined. Injury severity has been associated with the clinical manifestation of PTE but there currently are no experiments directly addressing this issue. In this series of studies, a subthreshold dose of the seizure-inducing agent pentylenetetrazole (PTZ) will be given at several post-traumatic time points to determine if injury severity- dependent changes in seizure threshold occur. In Specific Aim 2, evidence for alterations in local hippocampal circuit activity after trauma due to an imbalance in inhibitory (GABAA) and excitatory (NR2B) receptor function will be assessed. These studies will determine if changes in receptor localization seen after status epilepticus influence the development of seizure susceptibility after TBI. In addition, patterns of neuronal vulnerability in hippocampal regions as well as evidence for mossy fiber sprouting will be conducted to determine if these traumatic consequences can be correlated with changes in seizure threshold. Quantitative immunocytochemical, western blotting and in situ hybridization approaches for regional and cellular protein and mRNA assessment will be performed to determine these injury severity-dependent changes. Finally, in Specific Aim 3, a novel combination treatment strategy including modest posttraumatic hypothermia combined with a NR2B receptor blocker (Ro 25,6981) will be tested. The benefits of modest hypothermia are well documented after CNS injury but are unknown for PTE. Therefore, this combination approach may be the key to providing pre-clinical efficacy data in treating PTE. The benefits and limitations of single treatment paradigms will also be directly compared to this combination approach to assess therapeutic window, dose response as well as therapeutic efficacy. Based on preliminary findings, this combination approach should provide protection against neuronal drop-out, receptor vulnerability as well as behavioral outcome measures including seizure activity and cognitive function. The proposed studies will be performed by a group of experienced investigators that have a proven track record in the pathophysiology and treatment of TBI. Data from these studies could potentially be used to support clinical trials targeting PTE in this vulnerable patient population.
PUBLIC HEALTH RELEVANCE:
Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in the United States and is a subsequent risk factor for epilepsy. TBI not only effects civilian populations but is now known as the "signature injury" of the recent wars in Iraq and Afghanistan. In addition to cognitive problems associated with all types of TBI, posttraumatic seizure incidence rates will undoubtedly be prevalent in returning soldiers as assessment of these veterans is analyzed. However, there are currently no effective treatment strategies for the prevention of posttraumatic epilepsy (PTE). The present proposal will build on recent investigations to study injury severity- dependent changes on seizure susceptibility and associated cognitive dysfunction along with targeting pathomechanisms that would be amenable to treatment. It is anticipated that findings from this proposal will have an impact on the way we treat PTE in both military as well as civilian populations.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Helen M Bramlett其他文献
Helen M Bramlett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Helen M Bramlett', 18)}}的其他基金
Therapeutic interventions for post-stroke rehabilitation
中风后康复的治疗干预
- 批准号:
10542336 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Therapeutic interventions for post-stroke rehabilitation
中风后康复的治疗干预
- 批准号:
10314765 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Role of ryanodine receptor dysfunction after spinal cord injury
兰尼碱受体功能障碍在脊髓损伤后的作用
- 批准号:
9751868 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Role of ryanodine receptor dysfunction after spinal cord injury
兰尼碱受体功能障碍在脊髓损伤后的作用
- 批准号:
10515284 - 财政年份:2017
- 资助金额:
-- - 项目类别:
33rd Annual National Neurotrauma Society (NNS) Symposium
第 33 届国家神经创伤协会 (NNS) 年度研讨会
- 批准号:
8985809 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Novel Treatment Strategies for Targeting Posttraumatic Epilepsy
针对创伤后癫痫的新治疗策略
- 批准号:
8391542 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Novel Treatment Strategies for Targeting Posttraumatic Epilepsy
针对创伤后癫痫的新治疗策略
- 批准号:
8039007 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Novel Treatment Strategies for Targeting Posttraumatic Epilepsy
针对创伤后癫痫的新治疗策略
- 批准号:
8242623 - 财政年份:2010
- 资助金额:
-- - 项目类别:
相似海外基金
Drought and Climate Resilience of Smallholders in Afghanistan: Needs and Preferences Analysis
阿富汗小农的干旱和气候抵御能力:需求和偏好分析
- 批准号:
24K16366 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
'Diaspora States' in Somalia and Afghanistan: New Perspectives on Post-War Politics, Dual Citizenship and International Statebuilding
索马里和阿富汗的“侨民国家”:战后政治、双重国籍和国际国家建设的新视角
- 批准号:
EP/X022048/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship
Improving learning outcomes in Afghanistan and Pakistan in the midst of COVID-19 through Community based system dynamics and project-based learning
通过基于社区的系统动态和基于项目的学习,在 COVID-19 期间改善阿富汗和巴基斯坦的学习成果
- 批准号:
ES/X014088/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
On Politics and Justice: British Military Justice following War Crimes Allegations in Iraq and Afghanistan, 2001-present
论政治与司法:2001 年至今,伊拉克和阿富汗战争罪指控后的英国军事司法
- 批准号:
2745904 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship
U.S and Afghanistan - why the nation-building project failed?
美国和阿富汗——国家建设项目为何失败?
- 批准号:
22K01385 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Market Economy and Conflict; Disjuncture between the Politics and Economics of Statebuilding in Afghanistan during 2001-2021
市场经济与冲突;
- 批准号:
ES/X006832/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Fellowship
Analysis of the structure of conflict between ethnicities in the transformation of national integration policy in Afghanistan
阿富汗民族融合政策转型中的族群冲突结构分析
- 批准号:
19K20529 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era Veterans
神经类固醇干预伊拉克/阿富汗时期退伍军人的创伤后应激障碍
- 批准号:
10417141 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era Veterans
神经类固醇干预伊拉克/阿富汗时期退伍军人的创伤后应激障碍
- 批准号:
10589071 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A pilot assessment of miltefosine's efficacy and tolerability for treating cutaneous Leishmania tropica in Afghanistan
在阿富汗对米替福辛治疗皮肤热带利什曼原虫的疗效和耐受性进行初步评估
- 批准号:
MR/R018391/1 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




